Based on the above results, we aimed to screen active molecules that inhibited the deubiquitination effect of USP7 on YY1, which can further inhibit the effect of YY1 on EMT and inhibit the malignant progression of HCC. Here, USP7 is linked to hepatocellular carcinoma.